SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001280776-22-000017
Filing Date
2022-08-04
Accepted
2022-08-04 07:01:52
Documents
63
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vtl-20220630.htm   iXBRL 10-Q 1059440
2 EX-4.2 exhibit4211111.htm EX-4.2 17697
3 EX-31.1 imux-063022xexhibit311.htm EX-31.1 8620
4 EX-31.2 imux-063022xexhibit312.htm EX-31.2 8609
5 EX-32.1 imux-063022xexhibit321.htm EX-32.1 4899
6 EX-32.2 imux-063022xexhibit322.htm EX-32.2 4889
12 vtl-20220630_g1.jpg GRAPHIC 933830
  Complete submission text file 0001280776-22-000017.txt   7084947

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtl-20220630.xsd EX-101.SCH 35331
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtl-20220630_cal.xml EX-101.CAL 47863
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtl-20220630_def.xml EX-101.DEF 170215
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtl-20220630_lab.xml EX-101.LAB 447005
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtl-20220630_pre.xml EX-101.PRE 290614
57 EXTRACTED XBRL INSTANCE DOCUMENT vtl-20220630_htm.xml XML 740564
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

IRS No.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36201 | Film No.: 221134581
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences